First “Farm”aceuticals Grown in Carrots

Allison Guy
May 6th 2012

The United States Food and Drug Administration recently approved Elelyso, the first drug to be grown in genetically modified plant cells. Produced in carrot cells, this drug helps to treat the symptoms of Gaucher disease, a genetic disorder that causes bruising, anemia and low blood platelets.

Israeli scientists were able to insert a gene that codes for a human enzyme into carrot cells, causing the cells to produce the same protein that Gaucher patients lack. This new method should help prevent drug shortages that have affected Gaucher sufferers in the past, as well as being cheaper and less prone to infection than animal cells. Soon mothers may be telling their children to eat carrots, not just for better eyesight, but for better health across the board.

Story via Nature. Photo via Flickr user Loose Ends

Share your thoughts and join the technology debate!

Be the first to comment

What is your view on the coronavirus?


Siri Beerends: I really embrace the idea that viruses can teach us a lesson in modesty. It is necessary that our position as the dominant species on the planet is being challenged. I also agree that it is a mistake to think that we are becoming Gods. But unfortunately, this is actually what is happening now. Corona doesn’t teach us to be modest, it teaches us how we can -as quickly as possible- go back to business as usual: saving our capitalistic economy.

Comment
Already a member? Login.